WO2025074394 - A PROCESS FOR THE PREPARATION OF BELZUTIFAN AND ITS NOVEL INTERMEDIATES THEREOF

National phase entry is expected:
Publication Number WO/2025/074394
Publication Date 10.04.2025
International Application No. PCT/IN2024/051950
International Filing Date 04.10.2024
Title **
[English] A PROCESS FOR THE PREPARATION OF BELZUTIFAN AND ITS NOVEL INTERMEDIATES THEREOF
[French] PROCESSUS DE PRÉPARATION DE BELZUTIFAN ET DE SES NOUVEAUX INTERMÉDIAIRES
Applicants **
NATCO PHARMA LIMITED
Inventors
KONDURI, Srinivasa Krishna Murthy
SANAPUREDDY, Jagan Mohan Reddy
REMELLA, Ravi Kumar
GANGANAMONI, Srinivasulu
YATAM, Annpurna Phani
MOODE, Madhu Naik
POTHABATHULA, Govinda Raju
KOKKU, Santhosh Kumar
AMASA, Vinod Kumar
SIRIGIREDDY, Balakrishna Reddy
RAMPALLI, Sriram
MUDDASANI, Pulla Reddy
NANNAPANENI, Venkaiah Chowdary
Priority Data
202341067140   06.10.2023   IN
Application details
Total Number of Claims/PCT *
Number of Independent Claims *
Number of Priorities *
Number of Multi-Dependent Claims *
Number of Drawings *
Pages for Publication *
Number of Pages with Drawings *
Pages of Specification *
*
Number of Office Actions *
*
International Searching Authority
*
Recordal of a Change of the Applicant's Name/Address
*
Type of Assignment
*
Applicant's Legal Status
*
*
*
*
*
*
Entry into National Phase under
*
Patent Delivery
*
Translation

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country StagesTotal
China Filing, Examination, Granting2102
EPO Filing, Examination, Granting11870
Japan Filing, Examination, Granting2110
South Korea Filing, Examination, Granting1991
USA Filing, Examination, Granting4740
MasterCard Visa
Total: 22,813

The term for entry into the National Phase has expired. This quotation is for informational purposes only

Contact Us
Abstract[English] The present invention relates to a process for the preparation of 3-[[(1S,2S,3R)- 2,3-Difluoro-2,3-dihydro-1-hydroxy-7-(methylsulfonyl)-1H-inden-4-yl]oxy]-5- fluorobenzonitrile compound of formula-1 which is represented by the following structural formula:[French] La présente invention concerne un processus de préparation d'un composé 3-[[(1S,2S,3R)-2,3-difluoro-2,3-dihydro-1-hydroxy-7-(méthylsulfonyl)- H-indén-4-yl]oxy]-5-fluorobenzonitrile de formule-1, qui est représenté par la formule structurale ci-après.

Rejoining the server...